GlassScriptPhysician profile
Ellen Taylor Debarge
NPI 1255960381
$1,771.82
in general payments reported to CMS, 2019-2025
21 companies · $227 in 2025
The $227 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $93.55 · 2022: $738 · 2023: $382 · 2024: $331 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $940.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $939.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $258.18 | 2022-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $231.63 | 2022-2024 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $186.74 | 2021-2025 | |
| Pfizer INC. | $182.61 | 2022-2025 | |
| Glaxosmithkline, LLC. | $163.61 | 2022-2024 | Bexsero, Pediarix, Shingrix |
| Organon LLC | $121.06 | 2021-2023 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $94.47 | 2022-2023 | |
| Gilead Sciences, INC. | $71.68 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $70.44 | 2021-2023 | |
| Exact Sciences Corporation | $62.13 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $61.75 | 2022-2023 | Gardasil 9, Vaxelis, Rotateq |
| Sanofi Pasteur INC. | $50.53 | 2022-2024 | |
| Spr Therapeutics, INC | $46.57 | 2025 | Sprint Pns System |
| Teva Pharmaceuticals USA, INC. | $26.25 | 2023 | Uzedy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.67 | 2024 | Jardiance, Synjardy |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $23.56 | 2022 | |
| Viiv Healthcare Company | $22.66 | 2025 | Apretude |
| Dexcom, INC. | $20.67 | 2024 | Dexcom G6 Transmitter |
| Takeda Pharmaceuticals U.S.A., INC. | $19.38 | 2024 | Trintellix |
| Alkermes, INC. | $18.58 | 2025 | Aristada, Lybalvi |
| Evofem Biosciences, INC. | $13.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Debarge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.